PKL BILIRRUBINA DIRECTA
Mexico·Clase I·III. DIAGNOSTIC AGENTS·AXMILAB, S.A. DE C.V.·Registered November 02, 2022PRUEBAPARALADETERMINACIÓNCUANTITATIVAINVITRODE BILIRRUBINA DIRECTA EN SUERO O PLASMA HUMANO.
TEST FOR THE QUANTITATIVE DETERMINATION INVITRODE DIRECT BILIRUBIN IN HUMAN SERUM OR PLASMA.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA DETERMINARBILIRRUBINA
- Trade Name (English)
- BILIRUBIN TEST
- Analysis ID
- 99R2022 SSA
- Registration Date
- November 02, 2022
- Name (Spanish)
- AXMILAB, S.A. DE C.V.
- Name (English)
- AXMILAB, S.A. DE C.V.
Access comprehensive regulatory information for PKL BILIRRUBINA DIRECTA (PKL DIRECT BILIRUBIN) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 99R2022 SSA and manufactured by AXMILAB, S.A. DE C.V.. The device was registered on November 02, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.